Bilateral choroidopathy in systemic lupus erythematosus.

Abstract:

:We report a case of bilateral choroidopathy in a 35-year-old woman with systemic lupus erythematosus (SLE) diagnosed 3 years previously, and treated with hydroxychloroquine and steroids that ceased 6 months before ocular signs. She complained about rapid bilateral blurred vision with a severe loss of visual acuity. Fluorescein angiography found multiple leakage points in the posterior pole of the pigment epithelium. Ocular coherence tomography (OCT) and fundoscopy showed bilateral retinal detachments. Lupus choroidopathy was diagnosed and high steroids were given intravenously and allowed a rapid improvement. Visual acuity, fundoscopy, retinal angiography and OCT were normalized at 2 months. Choroidopathy is rarely reported in lupus and only about 30 patients are found in the literature.

journal_name

Lupus

journal_title

Lupus

authors

Edouard S,Douat J,Sailler L,Arlet P,Astudillo L

doi

10.1177/0961203311398510

subject

Has Abstract

pub_date

2011-10-01 00:00:00

pages

1209-10

issue

11

eissn

0961-2033

issn

1477-0962

pii

0961203311398510

journal_volume

20

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the clinical characteristics, imaging changes and early diagnostic methods of neuropsychiatric systemic lupus erythematosus (NPSLE). METHODS:Thirty-five SLE patients, of which 16 had overt neuropsychiatric symptoms, underwent examination for multiple autoantibodies, including anti-double-stran...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319861677

    authors: Jia J,Xie J,Li H,Wei H,Li X,Hu J,Meng D,Zhang Y,Zhang X

    更新日期:2019-08-01 00:00:00

  • Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.

    abstract:BACKGROUND:Current non-invasive methods of assessing disease activity in systemic lupus erythematosus (SLE) are of limited sensitivity and specificity. Testing includes acute phase markers, autoantibodies and complement levels. Although measurements of dsDNA antibodies and complement C3/C4 levels are routine, they rema...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319845487

    authors: Adhya Z,El Anbari M,Anwar S,Mortimer A,Marr N,Karim MY

    更新日期:2019-05-01 00:00:00

  • Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis.

    abstract::Objective We aimed to evaluate the relationship between telomere length and systemic lupus erythematosus (SLE). Methods PUBMED and EMBASE databases were searched; meta-analyses were performed comparing telomere length in SLE patients and healthy controls, and on SLE patients in subgroups based on ethnicity, sample typ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203316662721

    authors: Lee YH,Jung JH,Seo YH,Kim JH,Choi SJ,Ji JD,Song GG

    更新日期:2017-03-01 00:00:00

  • Serum level of anti-α-enolase antibody in untreated systemic lupus erythematosus patients correlates with 24-hour urine protein and D-dimer.

    abstract::Objective The objective of this report is to evaluate the prevalence and clinico-serological correlations of anti-α-enolase antibody (Ab) in patients with systemic lupus erythematosus (SLE). Methods Thirty-two untreated patients with SLE and 20 age- and sex-matched healthy controls were evaluated by rheumatologic exam...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317721752

    authors: Li M,Li J,Wang J,Li Y,Yang P

    更新日期:2018-01-01 00:00:00

  • Belimumab for systemic lupus erythematosus: a practice-based view.

    abstract::Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with multiple organ involvement. B-lymphocyte activity plays a pivotal role in the development and course of the disease. A newly developed agent called belimumab has recently been approved to treat active, autoantibody positive SLE as an add-on to st...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313476154

    authors: Parodis I,Axelsson M,Gunnarsson I

    更新日期:2013-04-01 00:00:00

  • Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.

    abstract::HIN200 is a human IFN-inducible gene and homologous to murine IFI202 gene, which was identified as a candidate gene for SLE susceptibility in lupus mouse model. We determined these gene expressions in leukocytes from 20 SLE patients and 10 healthy controls and in renal biopsies from 29 SLE patients and 15 kidney donor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106699

    authors: Kimkong I,Avihingsanon Y,Hirankarn N

    更新日期:2009-10-01 00:00:00

  • Clinical and financial burden of active lupus in Greece: a nationwide study.

    abstract::Analyses of the medical and economic burden of chronic disorders such as systemic lupus erythematosus (SLE) are valuable for clinical and health policy decisions. We performed a chart-based review of 215 adult SLE patients with active autoantibody-positive disease at the predefined ratio of 30% severe (involvement of ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316642310

    authors: Bertsias G,Karampli E,Sidiropoulos P,Gergianaki I,Drosos A,Sakkas L,Garyfallos A,Tzioufas A,Vassilopoulos D,Tsalapaki C,Sfikakis P,Panopoulos S,Athanasakis K,Perna A,Psomali D,Kyriopoulos J,Boumpas D

    更新日期:2016-10-01 00:00:00

  • Photoprotective habits in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can involve multiple organ systems. Exposure to ultraviolet radiation (UVR) can exacerbate pre-existing SLE, and can even induce systemic manifestations. This study aimed to investigate the photoprotective habits of children with SLE and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320930098

    authors: Janthongsri T,Wisuthsarewong W,Nitiyarom R

    更新日期:2020-07-01 00:00:00

  • Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.

    abstract::Numerous drugs have been linked to the induction or exacerbation of systemic cutaneous lupus erythematosus (SCLE). This report presents the third case of the biologic abatacept as an exacerbating medication for SCLE. A 73-year old woman with a remote history of subacute cutaneous lupus and rheumatoid arthritis, well c...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320981146

    authors: Figueredo Zamora E,Callen JP,Schadt CR

    更新日期:2020-12-22 00:00:00

  • Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.

    abstract::Background While thrombopoeitin (TPO) agonists that act to simulate platelet production have been approved for use in steroid-refractory chronic immune thrombocytopenia purpura (ITP), there are few data on the safety and efficacy of these medications in patients with concurrent systemic lupus erythematosus (SLE) or an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318770023

    authors: Lusa A,Carlson A

    更新日期:2018-09-01 00:00:00

  • Induced abortions in women with systemic lupus erythematosus.

    abstract:OBJECTIVES:To determine the rates of induced abortions in women with systemic lupus erythematosus (SLE) compared to women from the general population and assess disease-related predictors of induced abortion in women with SLE. METHODS:We identified women with SLE (15-45 years) and determined the number of induced abor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320979741

    authors: Venne K,Scott S,Bernatsky S,Vinet E

    更新日期:2020-12-15 00:00:00

  • Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617845

    authors: Tselios K,Gladman DD,Su J,Urowitz MB

    更新日期:2016-04-01 00:00:00

  • Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.

    abstract::The purpose of study was to determine the nature, outcomes and associated risk factors of invasive fungal infection (IFI) in patients with systemic lupus erythematosus (SLE), and compare the incidence of IFI in patients with rheumatoid arthritis (RA). A total of 1155 patients with SLE and 2004 patients with RA were re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309103081

    authors: Kim HJ,Park YJ,Kim WU,Park SH,Cho CS

    更新日期:2009-06-01 00:00:00

  • Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies.

    abstract::Monoclonal antiphospholipid antibodies (aPL) have been utilized to dissect the relationship between their sequence, structure, binding and biological properties relevant to the pathogenesis of the antiphospholipid syndrome. In particular, sequence analysis of aPL has highlighted the clustering of certain amino acid re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360809

    authors: Lambrianides A,Giles IP

    更新日期:2010-04-01 00:00:00

  • Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital.

    abstract::Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The likelihood of these serio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu433oa

    authors: Lian TY,Edwards CJ,Chan SP,Chng HH

    更新日期:2003-01-01 00:00:00

  • In vivo models of thrombosis for the antiphospholipid syndrome.

    abstract::Utilizing this unique animal model of thrombosis we demonstrated that human (IgG, IgM or IgA) polyclonal and monoclonal antiphospholipid antibodies derived from APS patients have a significant enhancing effect on thrombus formation. This effect is reversed by treatment of the mice with hydroxychloroquine (plaquenil). ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500524

    authors: Pierangeli SS,Harris EN

    更新日期:1996-10-01 00:00:00

  • Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.

    abstract::The levels of 'putative' anti-idiotypic antibodies reactive with F(ab')2 fragments of affinity purified DNA binding antibodies from five SLE patients were measured in the serum of active and inactive systemic lupus erythematosus (SLE) patients, their relatives, spouses and healthy non-related individuals. Serum anti-i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678919958

    authors: Williams WM,Isenberg DA

    更新日期:1998-01-01 00:00:00

  • Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.

    abstract::Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of e...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309358187

    authors: Ortega LM,Schultz DR,Lenz O,Pardo V,Contreras GN

    更新日期:2010-04-01 00:00:00

  • Why not work on T and NK cells in the Kunkel laboratory?

    abstract::Coming from Hans Wigzell's laboratory in Uppsala, Sweden, I joined the Kunkel laboratory in 1981 to spend a post-doctoral fellowship period financed by the German Research Organization. While I initially worked with Nick Chiorazzi in an attempt to generate monoclonal antibody-secreting human B-cell hybridomas, I later...

    journal_title:Lupus

    pub_type: 传,历史文章,杂志文章

    doi:10.1191/0961203303lu355xx

    authors: Kabelitz D

    更新日期:2003-01-01 00:00:00

  • Fibromyalgia in Indian patients with SLE.

    abstract::One hundred and fifty-eight patients with SLE were prospectively studied at a tertiary referral centre in India to ascertain the prevalence and clinical profile of fibromyalgia (FM) in Indian patients with lupus. An attempt was made to determine whether socio-demographic factors or disease characteristics differ in SL...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920497

    authors: Handa R,Aggarwal P,Wali JP,Wig N,Dwivedi SN

    更新日期:1998-01-01 00:00:00

  • Infections in infancy and the presence of antinuclear antibodies in adult life.

    abstract::There has been limited success defining environmental factors important to the development of connective tissue diseases such as systemic lupus erythematosus (SLE). Recent work has suggested that the perinatal environment may be important. To investigate this we measured antinuclear antibodies (ANA) in a general popul...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2286oa

    authors: Edwards CJ,Syddall H,Goswami R,Goswami P,Dennison EM,Cooper C

    更新日期:2006-01-01 00:00:00

  • Objectively measured physical activity and its influence on physical capacity and clinical parameters in patients with primary Sjögren's syndrome.

    abstract::Objective The objectives of this paper are to objectively measure habitual physical activity levels in patients with primary Sjögren's syndrome (pSS) with mild disease activity and to determine to which extent it may be associated with physical capacity and function and clinical features. Methods In this cross-section...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316674819

    authors: Dassouki T,Benatti FB,Pinto AJ,Roschel H,Lima FR,Augusto K,Pasoto S,Pereira RMR,Gualano B,de Sá Pinto AL

    更新日期:2017-06-01 00:00:00

  • Infodemiology of systemic lupus erythematous using Google Trends.

    abstract::Objective People affected by chronic rheumatic conditions, such as systemic lupus erythematosus (SLE), frequently rely on the Internet and search engines to look for terms related to their disease and its possible causes, symptoms and treatments. 'Infodemiology' and 'infoveillance' are two recent terms created to desc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317691372

    authors: Radin M,Sciascia S

    更新日期:2017-07-01 00:00:00

  • The significance of anticardiolipin antibodies in patients with lupus nephritis.

    abstract::The objective of this study was to determine whether anticardiolipin antibodies (ACL) in SLE patients are associated with a specific pattern of lupus nephritis and/or with renal microvascular changes. Patients with SLE, followed prospectively between June 1991-May 1994 at The Wellesley Hospital Lupus Clinic, who under...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500113

    authors: Abu-Shakra M,Urowitz MB,Gladman DD,Ritchie S

    更新日期:1996-02-01 00:00:00

  • Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.

    abstract::Legionnaire's disease (LD) is most commonly caused by Legionella pneumophila (L. pneumophila). In immunocompromised patients LD can cause necrosis of the lung parenchyma with abscess formation and cavitation. Systemic lupus erythematosus (SLE) is an autoimmune disorder with features of both primary and secondary immun...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203321990102

    authors: Khokher W,Kesireddy N,Adunse J,Mudiyanselage PH,Iftikhar S,Assaly R

    更新日期:2021-01-26 00:00:00

  • Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

    abstract::Systemic lupus erythematosus (SLE) is an autoantibody and immune complex mediated disease. However, it is the ensuing inflammatory process that leads to irreversible organ damage. In fact several murine models of SLE suggest that this inflammatory organ damage can be prevented even in the presence of autoantibodies. G...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu1024oa

    authors: Aringer M,Smolen JS

    更新日期:2004-01-01 00:00:00

  • Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity.

    abstract::With a cross sectional study of 465 consecutive systemic lupus erythematosus (SLE) patients tested for 13 autoantibodies (Aab) and two idiotypes we determined the prevalence of Aab according to disease activity, both general and at particular organ systems. Seventy seven percent of SLE sera had at least one Aab and 56...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600503

    authors: Villarreal GM,Drenkard C,Villa AR,Slor H,Shafrir S,Bakimer R,Shoenfeld Y,Alarcón-Segovia D

    更新日期:1997-01-01 00:00:00

  • Lupus erythematosus proliferative glomerulonephritis in fetus.

    abstract::We report the case of a fetus with proliferative glomerulonephritis in the context of maternal systemic lupus erythematosus (SLE). The pattern of the renal lesions correspond to the class III of revisited WHO classification of glomerulonephritis in SLE. Amniotic fluid analysis showed a high level of albumin and the pr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2045cr

    authors: Daïkha-Dahmane F,Bault JP,Molina-Gomes D,Hillion D,Ville Y

    更新日期:2005-01-01 00:00:00

  • Reactivation of systemic lupus erythematosus in a dialysis patient after tuberculous peritonitis.

    abstract::The disease activity of patients suffering from lupus nephritis usually becomes quiescent after the onset of end stage renal failure. Reactivation of lupus activity, especially after a long period of dialysis, is uncommon. Factors that might trigger off lupus reactivation after dialysis have not been well defined. We ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu096cr

    authors: Lui SL,Lam MF,Tse KC,Lo WK

    更新日期:2002-01-01 00:00:00

  • Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

    abstract:OBJECTIVE:The objective of this paper is to evaluate whether the different International Society of Nephrology/Renal Pathology Society (ISN/RPS) classes of proliferative lupus nephritis (LN) have a distinct baseline presentation, short-term response to immunosuppression (IS) and long-term prognosis. METHODS:Ninety-eig...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313514623

    authors: Vandepapelière J,Aydin S,Cosyns JP,Depresseux G,Jadoul M,Houssiau FA

    更新日期:2014-02-01 00:00:00